loading
Inmed Pharmaceuticals Inc stock is traded at $3.1212, with a volume of 5,405. It is up +1.01% in the last 24 hours and up +50.42% over the past month. InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
See More
Previous Close:
$3.09
Open:
$3.2
24h Volume:
5,405
Relative Volume:
0.12
Market Cap:
$3.61M
Revenue:
$4.96M
Net Income/Loss:
$-6.82M
P/E Ratio:
-0.0477
EPS:
-65.4
Net Cash Flow:
$-6.64M
1W Performance:
+4.39%
1M Performance:
+50.42%
6M Performance:
-40.09%
1Y Performance:
-40.86%
1-Day Range:
Value
$3.09
$3.20
1-Week Range:
Value
$2.8401
$3.20
52-Week Range:
Value
$1.72
$15.70

Inmed Pharmaceuticals Inc Stock (INM) Company Profile

Name
Name
Inmed Pharmaceuticals Inc
Name
Phone
(604) 669-7207
Name
Address
1445-885 WEST GEORGIA ST., VANCOUVER
Name
Employee
13
Name
Twitter
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
INM's Discussions on Twitter

Compare INM with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
INM
Inmed Pharmaceuticals Inc
3.125 3.61M 4.96M -6.82M -6.64M -65.40
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
158.04 68.46B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.35 47.30B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.75 45.89B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
15.89 17.90B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
296.58 13.14B 2.76B 1.11B 898.10M 22.77

Inmed Pharmaceuticals Inc Stock (INM) Latest News

pulisher
Apr 29, 2025

SEC Form PRE 14A filed by InMed Pharmaceuticals Inc. - Quantisnow

Apr 29, 2025
pulisher
Apr 26, 2025

InMed Pharmaceuticals cancels special shareholder meeting By Investing.com - Investing.com Canada

Apr 26, 2025
pulisher
Apr 25, 2025

InMed Pharmaceuticals cancels special shareholder meeting - Investing.com

Apr 25, 2025
pulisher
Apr 08, 2025

InMed Pharmaceuticals sets date for special shareholder meeting By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 08, 2025

InMed Pharmaceuticals sets date for special shareholder meeting - Investing.com

Apr 08, 2025
pulisher
Apr 07, 2025

InMed Pharmaceuticals stock hits 52-week low at $1.72 - Investing.com Australia

Apr 07, 2025
pulisher
Apr 07, 2025

InMed Pharmaceuticals stock hits 52-week low at $1.72 By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

InMed Pharmaceuticals : Expands on Announcement of Cannabinol (CBN) Therapeutic Leadership with New Website Content and CEO Interview - MarketScreener

Apr 07, 2025
pulisher
Mar 29, 2025

InMed Pharmaceuticals Stock Hits 52-Week Low at $2.34 By Investing.com - Investing.com India

Mar 29, 2025
pulisher
Mar 28, 2025

InMed Pharmaceuticals Stock Hits 52-Week Low at $2.34 - Investing.com India

Mar 28, 2025
pulisher
Mar 05, 2025

InMed Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Mar 05, 2025
pulisher
Feb 18, 2025

InMed Pharmaceuticals Struggles with Losses Amid Revenue Decline - MSN

Feb 18, 2025
pulisher
Feb 15, 2025

InMed Pharmaceuticals Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update - Defense World

Feb 15, 2025
pulisher
Feb 14, 2025

InMed Pharmaceuticals Board Reshuffle After Director Resignation - TipRanks

Feb 14, 2025
pulisher
Feb 13, 2025

InMed Pharmaceuticals Reports Q2 2025 Financial Results - TipRanks

Feb 13, 2025
pulisher
Feb 12, 2025

InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update - Yahoo Finance

Feb 12, 2025
pulisher
Feb 12, 2025

InMed Pharmaceuticals Inc. (INM) reports earnings - Quartz

Feb 12, 2025
pulisher
Feb 12, 2025

InMed Pharmaceuticals Inc. SEC 10-Q Report - TradingView

Feb 12, 2025
pulisher
Feb 06, 2025

InMed Advances INM-089 for Dry AMD Treatment with New Intravitreal Formulation - TipRanks

Feb 06, 2025
pulisher
Feb 04, 2025

Inmed selects IVT formulation of INM-089 for dry AMD - BioWorld Online

Feb 04, 2025
pulisher
Feb 03, 2025

InMed advances AMD treatment with promising IVT drug formulation - MSN

Feb 03, 2025
pulisher
Feb 03, 2025

Revolutionary Eye Drug INM-089 Achieves 10X Therapeutic Levels in Macular Degeneration Treatment - StockTitan

Feb 03, 2025
pulisher
Jan 24, 2025

Inmed Pharmaceuticals Inc (INM-Q) QuotePress Release - The Globe and Mail

Jan 24, 2025
pulisher
Jan 24, 2025

InMed Pharmaceuticals (NASDAQ: INM) Secures International Patent for Novel Compounds - Defense World

Jan 24, 2025
pulisher
Jan 22, 2025

InMed Pharmaceuticals Secures Key Patent for Cannabinoid Analogs - TipRanks

Jan 22, 2025
pulisher
Jan 22, 2025

InMed Pharmaceuticals secures international patent - Investing.com India

Jan 22, 2025
pulisher
Jan 22, 2025

InMed Pharmaceuticals Announces Granting of Patent for Novel Compounds - Newsfile

Jan 22, 2025
pulisher
Jan 22, 2025

InMed Secures Breakthrough 20-Year Patent in Mexico for Novel Cannabinoid Compounds - StockTitan

Jan 22, 2025
pulisher
Jan 22, 2025

Nano-Cap InMed Ignites Retail Frenzy As Stock Soars After Alzheimer's Drug Trial Shows Promise - Asianet Newsable

Jan 22, 2025
pulisher
Jan 22, 2025

InMed Pharmaceuticals (NASDAQ: INM) Announces Positive Results from INM-901 Alzheimer’s Disease Study - Defense World

Jan 22, 2025
pulisher
Jan 21, 2025

InMed Hails Alzheimer's Study, Stocks Shoot Higher - Baystreet.ca

Jan 21, 2025
pulisher
Jan 21, 2025

InMed announces ‘positive’ results from in vivo preclinical Alzheimer’s study - TipRanks

Jan 21, 2025
pulisher
Jan 21, 2025

InMed’s INM-901 Shows Promising Results in Preclinical Alzheimer’s Study - TipRanks

Jan 21, 2025
pulisher
Jan 21, 2025

InMed's INM-901 Demonstrates Statistically Significant Reduction in Neuroinflammation in a Long-Term Preclinical Alzheimer's Disease Study - Newsfile

Jan 21, 2025
pulisher
Jan 04, 2025

SABBY MANAGEMENT, LLC Acquires Shares in InMed Pharmaceuticals I - GuruFocus

Jan 04, 2025
pulisher
Dec 21, 2024

InMed Pharmaceuticals Inc. Holds 2024 Annual General Meeting – Elects Directors and Appoints Auditor - Defense World

Dec 21, 2024
pulisher
Dec 18, 2024

InMed Pharmaceuticals Director Faces Resignation After Shareholder Vote at Annual Meeting - StockTitan

Dec 18, 2024
pulisher
Dec 18, 2024

InMed Announces Results of 2024 Annual General Meeting - Newsfile

Dec 18, 2024
pulisher
Dec 18, 2024

InMed Pharmaceuticals Inc. announced that it expects to receive CAD 10 million in funding - Marketscreener.com

Dec 18, 2024
pulisher
Dec 17, 2024

InMed Enters Into Standby Equity Purchase Agreement - Newsfile

Dec 17, 2024
pulisher
Dec 17, 2024

Head-To-Head Review: InMed Pharmaceuticals (NASDAQ:INM) & Rocket Pharmaceuticals (NASDAQ:RCKT) - Defense World

Dec 17, 2024

Inmed Pharmaceuticals Inc Stock (INM) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$31.59
price up icon 3.32%
$9.775
price up icon 3.06%
$106.94
price up icon 0.96%
$8.69
price up icon 2.66%
$108.76
price up icon 2.04%
$296.21
price up icon 0.73%
Cap:     |  Volume (24h):